122 related articles for article (PubMed ID: 17628773)
1. [Organization of data and tissue banks for new prognostic factors in adenocarcinoma of the prostate. An interdisciplinary uropathologic approach].
Burger M; Hartmann A; Stoehr R; Hofstaedter F; Kneitz B; Riedmiller H; Wieland WF; Denzinger S
Urologe A; 2007 Sep; 46(9):1094. PubMed ID: 17628773
[No Abstract] [Full Text] [Related]
2. Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.
Sun X; Wang L; Li H; Jin C; Yu Y; Hou L; Liu X; Yu Y; Yan R; Xue F
Aging (Albany NY); 2021 Jun; 13(12):16024-16042. PubMed ID: 34133324
[TBL] [Abstract][Full Text] [Related]
3. [Molecular high throughput research in prostate carcinoma].
Schlomm T; Sültmann H; Poustka A; Sauter G; Hellwinkel OJ; Huland H
Urologe A; 2007 Sep; 46(9):1097-100. PubMed ID: 17628772
[No Abstract] [Full Text] [Related]
4. [Tumor suppressor RECK in prostate carcinoma. Decreased RECK expression as indicator of proteolytic imbalance].
Rabien A; Jung M; Fritzsche F; Loening SA; Kristiansen G; Jung K
Urologe A; 2007 Sep; 46(9):1081-2. PubMed ID: 17628776
[No Abstract] [Full Text] [Related]
5. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract][Full Text] [Related]
6. [Human kallikreins as tumor markers. Validation of potential marker of prostate cancer in serum and tissue].
Rabien A; Kristiansen G; Diamandis EP; Jung K; Stephan C
Urologe A; 2007 Sep; 46(9):1070-1. PubMed ID: 17605120
[No Abstract] [Full Text] [Related]
7. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.
Halvorsen OJ; Høstmark J; Haukaas S; Høisaeter PA; Akslen LA
Cancer; 2000 Jan; 88(2):416-24. PubMed ID: 10640976
[TBL] [Abstract][Full Text] [Related]
8. Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer.
Yu JJ; Yan T
Aging Male; 2010 Sep; 13(3):159-65. PubMed ID: 20136572
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
[TBL] [Abstract][Full Text] [Related]
10. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in prostate adenocarcinoma.
Sciarra A
Eur Urol; 2007 Nov; 52(5):1373. PubMed ID: 17985422
[No Abstract] [Full Text] [Related]
12. L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.
Yanagisawa N; Satoh T; Hana K; Ichinoe M; Nakada N; Endou H; Okayasu I; Murakumo Y
Cancer Biomark; 2015; 15(4):365-74. PubMed ID: 25835180
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
[TBL] [Abstract][Full Text] [Related]
14. [Quantifying gene expression in prostate carcinoma. Which endogenous reference genes are suitable?].
Jung M; Ohl F; Stephan C; Rabien A; Kristiansen G; Radonić A; Loening SA; Jung K
Urologe A; 2007 Sep; 46(9):1083-4. PubMed ID: 17628775
[No Abstract] [Full Text] [Related]
15. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Nat Commun; 2018 Jun; 9(1):2419. PubMed ID: 29925878
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic role of perineural invasion in prostate biopsy].
Gutiérrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
[TBL] [Abstract][Full Text] [Related]
17. Clinical pathology of prostate cancer: focus on diagnosis, predictive and prognostic factors and quality indicators.
Galosi AB; Montironi R; Mazzuchelli R; Muzzonigro G
Arch Ital Urol Androl; 2007 Mar; 79(1):45-51. PubMed ID: 17484408
[TBL] [Abstract][Full Text] [Related]
18. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
19. Independent prognostic value of the 67-kd laminin receptor in human prostate cancer.
Waltregny D; de Leval L; Ménard S; de Leval J; Castronovo V
J Natl Cancer Inst; 1997 Aug; 89(16):1224-7. PubMed ID: 9274918
[No Abstract] [Full Text] [Related]
20. Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.
Montanari E; Del Nero A; Gazzano G; Mangiarotti B; Bernardini P; Longo F; Cordima G; Itri E
Arch Ital Urol Androl; 2009 Mar; 81(1):9-12. PubMed ID: 19499751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
